Evaluation Of Renal Safety Of Raas Inhibitor Therapy: A Clinical And Pharmacovigilant Study
After initiating a renin-angiotensin-aldosterone system (raas) inhibitor, there is a risk of decreased renal functions or hyperkalaemia. Hence, biochemical monitoring tests for serum creatinine and potassium are warranted after therapy initiation and are mandatory by guidelines. However, adherenc...
| المؤلف الرئيسي: | |
|---|---|
| التنسيق: | أطروحة |
| اللغة: | الإنجليزية |
| منشور في: |
2024
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | http://eprints.usm.my/62705/ |
| Abstract | Abstract here |